Related Experiment Video
Updated: Feb 18, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Prognostic impact of vascular disease in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation
Ameenathul M Fawzy1, Arnaud Bisson2, Gregory Y H Lip3
1Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Insights
Patients with atrial fibrillation (AF) and vascular disease face increased risks of all-cause mortality, stroke, and major bleeding. Careful management of these conditions is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Epidemiology
Background:
- Vascular disease, including peripheral artery disease, coronary artery disease, and aortic disease, is linked to higher risks of atrial fibrillation (AF) and ischemic stroke (IS) in AF patients.
- Understanding the impact of vascular disease on AF prognosis is essential for clinical management.
Purpose of the Study:
- To investigate the effect of co-existing vascular disease on the prognosis of patients diagnosed with atrial fibrillation (AF).
Main Methods:
- A retrospective analysis included 8962 AF patients, categorized into groups with and without vascular disease.
- Outcomes assessed included a composite of death, stroke, thromboembolic events, all-cause mortality (ACM), stroke or systemic embolism (SSE), IS, hemorrhagic stroke, and major bleeding.
Main Results:
- Patients with vascular disease showed a higher univariate risk for ACM, SSE, IS, and major bleeding compared to those without.
- Multivariate analysis, after adjusting for CHA2DS2-VASc score and antithrombotic use, confirmed significantly increased risks of ACM, SSE, and major bleeding in AF patients with vascular disease.
- The increased risk for IS was no longer significant in multivariate analysis, and a non-significant lower risk for hemorrhagic stroke was observed in patients with vascular disease.
Conclusions:
- Atrial fibrillation patients with vascular disease face elevated risks of all-cause mortality, stroke or systemic embolism, and major bleeding.
- This patient group requires comprehensive management strategies focusing on risk factor control and tailored treatment.
- Further research is needed to fully elucidate the relationship between vascular disease and AF prognosis.
Background:
Vascular disease which comprises peripheral artery disease, significant coronary artery disease and aortic disease is associated with both an increased risk of atrial fibrillation (AF) and ischaemic stroke (IS) in AF patients.
Purpose:
We investigated the effect of vascular disease on the prognosis of AF patients.
Methods:
In this retrospective analysis, all patients with AF were identified and classified into 2 groups depending on the presence of vascular disease. 3 patients were excluded due to missing data. Primary outcome was a composite of death, stroke and thromboembolic events. Secondary outcomes included all-cause mortality (ACM), stroke or systemic embolism (SSE), IS, haemorrhagic stroke and major bleeding.
Results:
A total of 8962 patients were included; 3021 with vascular disease and 5941 without vascular disease and followed up over a mean period of 929±1082 days. On the univariate analysis, patients with vascular disease were at a higher risk of ACM hazard ratio (HR) 1.728 ((confidence interval (CI)1.549-1.928), SSE HR HR 1.477 (CI 1.274-1.714), IS HR 1.441 (CI 1.202-1.727), major bleeding HR 1.488 (CI 1.292-1.713) and a composite of death and SSE HR 1.643 (CI 1.489-1.812), compared to patients without vascular disease. On a multivariate analysis, after adjusting for components of the CHA2DS2VASc score, oral anticoagulation (warfarin) use and antiplatelet use, the increased risk of ACM HR 1.460 (CI 1.285-1.658), SSE HR 1.226 (CI 1.030-1.458) and major bleeding HR 1.186 (CI 1.005-1.400) remained statistically significant but the risk of IS was no longer significant, HR 1.187 (CI 0.960-1.469). Compared to those without vascular disease, patients with vascular disease were at a lower risk of haemorrhagic strokes but this was not significant.
Conclusion:
AF patients with vascular disease are at a higher risk of ACM, SSE and major bleeding compared to patients without vascular disease, indicating that patients with this combination require careful and holistic management in terms of risk factor control and treatment of the condition. Additional research is required to further characterise the relationship between the two.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease I: Introduction
Aortic Regurgitation III: Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests